| TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells A Biroccio, J Cherfils-Vicini, A Augereau, S Pinte, S Bauwens, J Ye, ... Nature cell biology 15 (7), 818-828, 2013 | 127 | 2013 |
| Ephrin-Eph signalling drives the asymmetric division of notochord/neural precursors in Ciona embryos V Picco, C Hudson, H Yasuo Oxford University Press for The Company of Biologists Limited 134 (8), 1491-1497, 2007 | 116 | 2007 |
| Linking JNK activity to the DNA damage response V Picco, G Pagès Genes & cancer 4 (9-10), 360-368, 2013 | 88 | 2013 |
| p120RasGAP mediates ephrin/Eph-dependent attenuation of FGF/ERK signals during cell fate specification in ascidian embryos N Haupaix, A Stolfi, C Sirour, V Picco, M Levine, L Christiaen, H Yasuo Development 140 (21), 4347-4352, 2013 | 42 | 2013 |
| Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma Y Cormerais, M Pagnuzzi‐Boncompagni, S Schrötter, S Giuliano, ... Journal of Cellular and Molecular Medicine 23 (4), 2711-2718, 2019 | 40 | 2019 |
| Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma Y Cormerais, M Pagnuzzi‐Boncompagni, S Schrötter, S Giuliano, ... Journal of Cellular and Molecular Medicine 23 (4), 2711-2718, 2019 | 40 | 2019 |
| The c-Jun N-terminal kinase prevents oxidative stress induced by UV and thermal stresses in corals and human cells L Courtial, V Picco, R Grover, Y Cormerais, C Rottier, A Labbe, G Pagès, ... Scientific Reports 7 (1), 45713, 2017 | 37 | 2017 |
| ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2 V Picco, I Coste, MJ Giraud-Panis, T Renno, E Gilson, G Pagès Oncotarget 7 (29), 46615, 2016 | 28 | 2016 |
| Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma Y Benhamou, V Picco, H Raybaud, A Sudaka, E Chamorey, S Brolih, ... Oncotarget 7 (28), 44236, 2016 | 27 | 2016 |
| Integrin-αvβ3 as a therapeutic target in glioblastoma: back to the future? W Echavidre, V Picco, M Faraggi, C Montemagno Pharmaceutics 14 (5), 1053, 2022 | 17 | 2022 |
| The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma Y Benhamou, V Picco, G Pages Oral oncology 57, 46-53, 2016 | 17 | 2016 |
| AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity S Brolih, SK Parks, V Vial, J Durivault, L Mostosi, J Pouysségur, G Pagès, ... Bmc Cancer 18, 1-10, 2018 | 15 | 2018 |
| Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma M Pagnuzzi-Boncompagni, V Picco, V Vial, V Planas-Bielsa, ... Cancers 14 (1), 70, 2021 | 9 | 2021 |
| VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells M Penco-Campillo, Y Comoglio, ÁJ Feliz Morel, R Hanna, J Durivault, ... Communications Biology 3 (1), 579, 2020 | 9 | 2020 |
| Validation of commercial ERK antibodies against the ERK orthologue of the scleractinian coral Stylophora pistillata L Courtial, V Picco, G Pagès, C Ferrier-Pagès F1000Research 6, 2017 | 4 | 2017 |
| Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells M Penco-Campillo, Y Comoglio, ÁJ Feliz Morel, R Hanna, J Durivault, ... Communications biology 3 (1), 758, 2020 | 2 | 2020 |
| Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future W Echavidre, D Fagret, M Faraggi, V Picco, C Montemagno Cancers 15 (19), 4839, 2023 | 1 | 2023 |
| Targeting of the ELR+ CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas M Penco-Campillo, C Molina, P Piris, N Soufi, M Carré, ... Cells 11 (23), 3933, 2022 | 1 | 2022 |
| Revealing the Ferroptotic Phenotype of Medulloblastoma F Segui, B Daher, C Gotorbe, J Pouyssegur, V Picco, M Vucetic JoVE (Journal of Visualized Experiments), e66645, 2024 | | 2024 |
| Integrin-αvβ3 is a therapeutically targetable fundamental factor in medulloblastoma tumorigenicity and radioresistance W Echavidre, J Durivault, C Gotorbe, T Blanchard, M Pagnuzzi, V Vial, ... Cancer Research Communications 3 (12), 2483-2496, 2023 | | 2023 |
